Secondary end-points:
- Definition ‘resistant prolactinomas’
- Assessment of current management
- Database on resistant prolactinomas
We thank the 7 sites that have already registered patients:
- National and Kapodistrian University of Athens – GREECE – 3 cases
- Vall d’Hebron- Barcelona – SPAIN – 6 cases
- University Clinical Centre of Serbia- Belgrade – SERBIA – 10 cases
- University Hospital Centre Zagreb- Zagreb – CROATIA – 9 cases
- MONIKI M.F. Vladimirskii Moscow Regional Scientific Research Institute & Almazov National Medical Research Centre – RUSSIA – 9 cases
- University of Naples – Federico II – ITALY – 1 case
All our members are invited to participate till the recruitment of 600 patients.
Thank you very much in advance for your participation In the PROLACTINOMA STUDY.
Dr. Krystallenia Alexandraki, [email protected]
Visit the official site: https://www.synergy2go.com/index.php
You must be logged in to post a comment.